logo

CARL

Carlsmed·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CARL fundamentals

Carlsmed (CARL) released its earnings on Nov 6, 2025: revenue was 13.10M (YoY +98.79%), beat estimates; EPS was -0.4 (YoY +80.58%), beat estimates.
Revenue / YoY
13.10M
+98.79%
EPS / YoY
-0.4
+80.58%
Report date
Nov 6, 2025
CARL Earnings Call Summary for Q3,2025
  • Revenue Surge: 98% YoY growth to $13.1M, fueled by 70%+ user expansion and 8-day lead times.
  • Profitability Boost: 76% gross margin, up 320bps YoY, from AI/3D-printing efficiencies.
  • Clinical Impact: 75% reduction in revision rates, targeting $13B spine fusion market.
  • Cervical Momentum: 50+ procedures completed, $21K CMS reimbursement, and 2026 outpatient rollout.
  • Financial Strength: $115M cash, expanded credit, and 2025 guidance of $49-50M (80-84% growth).
EPS
Revenue

Revenue & Expenses

CARL has released its 2025 Q3 earnings report, with revenue of 13.07M, reflecting a YoY change of 98.39%, and net profit of -8.53M, showing a YoY change of -9.13%. The Sankey diagram below clearly presents CARL's revenue sources and cost distribution.

Key Indicators

Carlsmed (CARL) key financial stats and ratios, covering profitability, financial health, and leverage.
Carlsmed (CARL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Carlsmed (CARL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Carlsmed (CARL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Carlsmed (CARL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Carlsmed (CARL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield